Adverse events402

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 402

Type	Event	Organ system	Group	Affected	At risk
other	Anaemia	Blood and lymphatic system disorders	Phase 1 Dose Determination Phase: Entinostat Plus Atezolizumab	0	8
other	Anaemia	Blood and lymphatic system disorders	Phase 2 Expansion: Entinostat Plus Atezolizumab	8	40
other	Anaemia	Blood and lymphatic system disorders	Phase 2 Expansion: Placebo Plus Atezolizumab	5	39
other	Anaemia	Blood and lymphatic system disorders	Phase 1 Dose Determination Phase: Entinostat Plus Atezolizumab	2	8
other	Anaemia	Blood and lymphatic system disorders	Phase 2 Expansion: Entinostat Plus Atezolizumab	0	40
other	Anaemia	Blood and lymphatic system disorders	Phase 2 Expansion: Placebo Plus Atezolizumab	0	39
other	Neutropenia	Blood and lymphatic system disorders	Phase 1 Dose Determination Phase: Entinostat Plus Atezolizumab	0	8
other	Neutropenia	Blood and lymphatic system disorders	Phase 2 Expansion: Entinostat Plus Atezolizumab	6	40
other	Neutropenia	Blood and lymphatic system disorders	Phase 2 Expansion: Placebo Plus Atezolizumab	1	39
other	Neutropenia	Blood and lymphatic system disorders	Phase 1 Dose Determination Phase: Entinostat Plus Atezolizumab	1	8
other	Neutropenia	Blood and lymphatic system disorders	Phase 2 Expansion: Entinostat Plus Atezolizumab	0	40
other	Neutropenia	Blood and lymphatic system disorders	Phase 2 Expansion: Placebo Plus Atezolizumab	0	39
other	Thrombocytopenia	Blood and lymphatic system disorders	Phase 1 Dose Determination Phase: Entinostat Plus Atezolizumab	0	8
other	Thrombocytopenia	Blood and lymphatic system disorders	Phase 2 Expansion: Entinostat Plus Atezolizumab	9	40
other	Thrombocytopenia	Blood and lymphatic system disorders	Phase 2 Expansion: Placebo Plus Atezolizumab	2	39
other	Thrombocytopenia	Blood and lymphatic system disorders	Phase 1 Dose Determination Phase: Entinostat Plus Atezolizumab	1	8
other	Thrombocytopenia	Blood and lymphatic system disorders	Phase 2 Expansion: Entinostat Plus Atezolizumab	0	40
other	Thrombocytopenia	Blood and lymphatic system disorders	Phase 2 Expansion: Placebo Plus Atezolizumab	0	39
other	Tachycardia	Cardiac disorders	Phase 1 Dose Determination Phase: Entinostat Plus Atezolizumab	1	8
other	Tachycardia	Cardiac disorders	Phase 2 Expansion: Entinostat Plus Atezolizumab	0	40

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02708680/events

API reference For AI assistants

Adverse events402

Sources 3

Read this list from software.